AlphaCentric Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-40,000	Closed	-$615K	–	210
2024 Q3	$615K	Sell	40,000 -60,000	-60%	-$1M	0.46%	63
2024 Q2	$1.63M	Buy	100,000 +55,000	+122%	+$888K	1.2%	22
2024 Q1	$832K	Buy	45,000 +19,000	+73%	+$471K	0.5%	73
2023 Q4	$814K	Sell	26,000 -24,000	-48%	-$573K	0.55%	61
2023 Q3	$1.04M	Hold	50,000	–	–	0.59%	59
2023 Q2	$1.2M	Hold	50,000	–	–	0.67%	56
2023 Q1	$941K	Hold	50,000	–	–	0.65%	55
2022 Q4	$796K	Buy	+50,000	New	+$782K	0.79%	45
2021 Q4	$1.2M	Sell	51,500 -22,000	-30%	-$442K	0.35%	22
2021 Q3	$1.22M	Buy	73,500 +60,000	+444%	+$1.16M	0.31%	16
2021 Q2	$329K	Buy	+13,500	New	+$305K	0.09%	83
2021 Q1	–	Sell	-2,350	Closed	-$126K	–	207
2020 Q4	$126K	Sell	2,350 -800	-25%	-$39.7K	0.05%	98
2020 Q3	$130K	Buy	+3,150	New	+$136K	0.06%	62